Microbot Medical Inc. has submitted a 510(k) premarket notification to the FDA for its LIBERTY Endovascular Robotic System, expecting clearance in Q2 2025 and U.S. commercialization thereafter.
AI Assistant
MICROBOT MEDICAL INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.